David Mark Milch - 07 Mar 2022 Form 4 Insider Report for Healthcare Capital Corp/DE

Role: Director, 10%+ Owner
Signature: /s/ Dr. David Milch
Issuer symbol: N/A
Transactions as of: 07 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2022, 20:30:25 UTC
Next filing: 18 Mar 2026
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCCC	Class A Common Stock	Options Exercise		+1,923,925			1,923,925	07 Mar 2022	See footnote	F2, F6
transaction	HCCC	Class A Common Stock	Other		-1,923,925	-100%		0	07 Mar 2022	See footnote	F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HCCC	Class B Common Stock	Other		-4,844,375	-70%		2,030,625	07 Mar 2022	Class A Common Stock	4,844,375		See footnote	F1, F3, F6
transaction	HCCC	Class B Common Stock	Other		-106,700	-5.3%		1,923,925	07 Mar 2022	Class A Common Stock	106,700		See footnote	F1, F4, F6
transaction	HCCC	Class B Common Stock	Options Exercise		-1,923,925	-100%		0	07 Mar 2022	Class A Common Stock	1,923,925		See footnote	F1, F2, F6
transaction	HCCC	Warrants	Other		-4,658,000	-68%		2,142,000	07 Mar 2022	Class A Common Stock	4,658,000	$11.50	See footnote	F3, F5, F6
transaction	HCCC	Warrants	Other		-2,142,000	-100%		0	07 Mar 2022	Class A Common Stock	2,142,000	$11.50	See footnote	F2, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

David Mark Milch is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	On March 7, 2022 (the "Closing Date"), Healthcare Capital Corp., a Delaware corporation ("HCCC"), and Alpha Tau Medical Ltd., a company organized under the laws of the State of Israel ("Alpha Tau"), consummated their previously announced business combination (the "Business Combination") pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), by and among HCCC, Alpha Tau and Archery Merger Sub Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Alpha Tau. On the Closing Date, pursuant to the terms of the Merger Agreement, each outstanding share of Class B common stock of HCCC converted into shares of Class A common stock of HCCC at a conversion ratio of one share of Class B common stock for one share of Class A common stock.
F2	Pursuant to the terms of the Merger Agreement, on the Closing Date, each outstanding share of Class A common stock of HCCC following the conversion described in footnote 1 above were exchanged for one newly issued Class A ordinary share of Alpha Tau and each warrant of HCCC was exchanged for one warrant of Alpha Tau.
F3	Pursuant to the terms of the Sponsor Support Agreement, dated as of July 7, 2021, as amended on February 17, 2022 and the Letter Agreement, dated as of the Closing Date, by and between HCCC, Alpha Tau, Healthcare Capital Sponsor LLC (the "Sponsor") and certain insiders, the Sponsor agreed to forfeit on the Closing Date, for no consideration, 4,844,375 shares of Class B common stock of HCCC and warrants to purchase 4,658,000 shares of Class A common stock of HCCC.
F4	Pursuant to the terms of the Letter Agreement, dated as of the Closing Date, by and between the Sponsor and Cantor Fitzgerald & Co., the Sponsor transferred 106,700 shares of Class B common stock of HCCC to Cantor for services provided in connection with the Company's initial public offering and the Business Combination.
F5	Pursuant to the terms thereof, the exercisability of the warrants was subject to the completion of the Business Combination. Each whole warrant will become exercisable to purchase one Class A ordinary share of Alpha Tau, commencing 30 days after the Closing Date and expiring five years following the Closing Date.
F6	The Sponsor is the record holder of the shares of common stock and warrants reported herein. Dr. Milch is the managing member of the Sponsor and has voting and investment discretion with respect to the common stock and warrants held of record by the Sponsor. By virtue of this relationship, Dr. Milch may be deemed to have beneficial ownership of the securities held of record by the Sponsor. He disclaims any beneficial ownership of the reported securities other than to the extent of any pecuniary interest they may have therein, directly or indirectly.